Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125186002 | 12518600 | 2 | F | 201605 | 20160923 | 20160630 | 20160928 | EXP | FR-009507513-1606FRA014175 | MERCK | 81.00 | YR | M | Y | 0.00000 | 20160928 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125186002 | 12518600 | 1 | PS | XELEVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, QD | Y | 21995 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 125186002 | 12518600 | 2 | SS | TOVIAZ | FESOTERODINE FUMARATE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | PROLONGED-RELEASE TABLET | QD | |||||
| 125186002 | 12518600 | 3 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 125186002 | 12518600 | 4 | SS | GUTRON | MIDODRINE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 125186002 | 12518600 | 5 | C | AMIODARONE HYDROCHLORIDE. | AMIODARONE HYDROCHLORIDE | 1 | Oral | U | 0 | ||||||||||
| 125186002 | 12518600 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | U | 0 | POWDER FOR ORAL SOLUTION | |||||||||
| 125186002 | 12518600 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 125186002 | 12518600 | 8 | C | INSULIN | INSULIN NOS | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125186002 | 12518600 | 1 | Type 2 diabetes mellitus |
| 125186002 | 12518600 | 2 | Pollakiuria |
| 125186002 | 12518600 | 3 | Cardiovascular disorder |
| 125186002 | 12518600 | 4 | Orthostatic hypotension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125186002 | 12518600 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125186002 | 12518600 | Condition aggravated | |
| 125186002 | 12518600 | Fall | |
| 125186002 | 12518600 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125186002 | 12518600 | 1 | 20160525 | 0 | ||
| 125186002 | 12518600 | 2 | 20160514 | 20160525 | 0 | |
| 125186002 | 12518600 | 3 | 20160525 | 0 | ||
| 125186002 | 12518600 | 4 | 20160530 | 0 |